TSVT — 2Seventy Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for 2Seventy Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS/A	PROSPECTUS/A	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	—	—	265	266	217
Net Total Accounts Receivable
Net Total Receivables	7.43	10.7	17	21	13.4
Prepaid Expenses
Total Current Assets	20.8	25.1	292	301	238
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	258	260	310	297	278
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	315	313	760	657	565
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	103	75.9	98.4	79.8	59.8
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	271	238	400	346	310
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	43.7	74.6	360	310	255
Total Liabilities & Shareholders' Equity	315	313	760	657	565
Total Common Shares Outstanding